Honorary Fellows are elected for life by the British Pharmacological Society in recognition of sustained excellence and leadership in science, healthcare, and public service.
The Honorary Fellowship includes Nobel Laureates, international prize-winners, long-standing members of the Society, and those who have advanced the disciplines of Pharmacology, Clinical Pharmacology and Therapeutics through research, leadership and contribution to the British Pharmacological Society.
Find out more and nominate individuals for Honorary Fellowship.
This Directory has been created to increase the visibility of our Honorary Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Honorary Fellows with similar areas of interest.
Here you can find profiles of each Honorary Fellow, including information on their institutional affiliation, year elected, primary professional setting, Affinity Group membership, along with a short biography.
Please click the magnifying glass icon to begin any searches.
Dr Melanie Lee, PhD, CBE, is CEO of LifeArc.
Gordon Lees served as Member of the BJP Editorial Board 1975-81; the Committee 1983-84; Secretary to the BJP Editorial Board 1984-90.
Robert J Lefkowitz, MD is James B Duke Professor of Medicine and Professor of Biochemistry and Chemistry at the Duke University Medical Center.
Hilary Little is a preclinical pharmacologist, currently a visiting Professor of Addiction Science at the Institute of Psychiatry, Psychology and Neuroscience, London.
As Head of the Animals in Science Regulation Unit in the Home Office until 2016, Judy MacArthur Clark was responsible for regulating the use of animals in research throughout the UK for over eight years.
Mandy’s research has focused on sex effects and interactions between serotonin and oestrogen metabolism in pulmonary arterial hypertension.
Emeritus Professor Charles A Marsden (b 1943) read Zoology at the University of London before going to the University of Southampton (MSc in Biochemical Pharmacology (1967), PhD in invertebrate neuropharmacology (1969) and DSc (1986)).
Fiona Marshall is Fiona Marshall is President of Novartis Biomedical Research, the company’s innovation engine, where she leads roughly 5,400 scientists and other associates across six research sites dedicated to the discovery of high-value medicines for patients.